glutathione parkinson's disease clinical trial Frontiers Glutathione & Parkinson's: Evidence, Biomarkers,
Description
doi: 10.1097/WNR.0000000000001596
Makris S, de Winde CM, Horsnell HL, Cantoral-Rebordinos JA, Finlay RE, Acton SE
P.CocucciS
Neonatal iron deficiency results in irreversible changes in dopamine function in rats
Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study
